Clinical Trials Directory

Trials / Conditions / Hospital Acquired Bacterial Pneumonia

Hospital Acquired Bacterial Pneumonia

9 registered clinical trials studyying Hospital Acquired Bacterial Pneumonia — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex
NCT06087536
Omnix Medical LtdPhase 2
RecruitingOptimising TREATment for Severe Gram-Negative Bacterial Infections
NCT07004049
National University of SingaporePhase 4
CompletedP3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available T
NCT05905055
Meiji Seika Pharma Co., Ltd.Phase 3
CompletedStudy to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With I
NCT03894046
Entasis TherapeuticsPhase 3
CompletedImipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquire
NCT03583333
Merck Sharp & Dohme LLCPhase 3
WithdrawnA Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ven
NCT03006679
Melinta Therapeutics, Inc.Phase 3
CompletedTelavancin Observational Use Registry (TOUR)
NCT02288234
Cumberland Pharmaceuticals—
CompletedEfficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections i
NCT02168946
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)Phase 3
CompletedStudy of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae
NCT02420366
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)—